Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Omni-Biotic Flora Plus+ (Institut AllergoSan)
- Development stage
- Unknown
- Lead developer
- Institut AllergoSan
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Omni-Biotic Flora Plus+ is a specialized oral synbiotic dietary supplement formulated to support and maintain healthy vaginal and intestinal flora, particularly in women. The product contains four specific human-origin Lactobacillus strains—Lactobacillus crispatus LBV88, Lactobacillus rhamnosus LBV96, Lactobacillus gasseri LBV150N, and Lactobacillus jensenii LBV116—designed to replenish beneficial microorganisms essential for balancing vaginal microflora and mitigating issues related to dysbiosis, such as bacterial vaginosis. Each 2 g sachet delivers at least 5 billion colony forming units (CFU) of these strains, augmented with prebiotic fructo-oligosaccharides (FOS) to promote bacterial growth and activity. The preparation is free from gluten, lactose, and animal proteins, making it suitable for vegans and safe during pregnancy and breastfeeding. The mechanism of action is based on oral administration of live bacteria that can colonize the intestinal and, subsequently, the vaginal environment, restoring the natural microbial balance essential for women's health. Developed according to scientific and clinical research, Omni-Biotic Flora Plus+ is marketed for dietary management of disturbed vaginal flora and can be used preventively or during periods of increased need, such as after antibiotics or hormonal changes.
- Brand names
- Omni-Biotic Flora Plus+
Beyond the preview
Go deeper on Omni-Biotic Flora Plus+ (Institut AllergoSan).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Omni-Biotic Flora Plus+ (Institut AllergoSan).